Cha Meditech, "Filler HyaFilia Achieved Twice its Original Goal
in Turkey... Establishing a Foothold in Europe"
Cha Meditech announced on the 30th
that the four export lineups of its own hyaluronic filler, "HyaFilia",
have achieved twice their original goal in the Turkish market, paving the way
for the company’s entry into Europe.
Turkey ranks 64th in global per-capita
GDP, but the size of its cosmetic surgery market ranked eighth in the world as recently
as 2018.
In particular, the CE certification obtained
in Turkey is also recognized in European countries, so the product can be
released in Europe through a simple procedure, Cha Meditech explained.
Currently, the company is negotiating to
export HyaFilia to the U.K. and Spain, and the company plans to enter 15
countries in Europe in the future.
In addition, the company said it will launch
four HyaFilia lineups for export to Russia next month, and it will also step up
efforts to expand the market in the Middle East.
HyaFilia’s lineup of S•M•V•I for export was
developed with a focus on volume-increasing effects. Cha Meditech emphasized
that its physical properties and safety have been significantly enhanced
compared to previous products. The company plans to deliver the message
"How She Makes V" to consumers in Europe, Russia, and the Middle
East, meaning that an injection of HyaFilia into the skin instantly creates the
desired shape and volume. In particular, the company plans to focus on the fact
that the product can be easily injected with a minimal amount of force,
minimizing risks of side effects, such as skin damage, bruises, and edema.
As the global spread of Corona 19 continues,
Cha Meditech is actively participating in KOTRA’s overseas branching project as
a new overseas business strategy at a time when it is difficult to make physical
business trips. KOTRA's overseas branching business supports export and
overseas expansion by acting as a local branch for domestic companies that desire
to go abroad. Already, Cha Meditech is targeting the markets, with KOTRA's
support, in three Latin American countries, two European countries, and three
Asian countries.
"We will continue to expand our
presence in Europe, Russia, and the Middle East by continuously discovering
local partners, beginning with the launch of 'HyaFilia S•M•V•I', which has
obtained the European certification," said Kim Seok-jin, CEO of Cha
Meditech. "Based on our excellent product and our technical skills, we
will expand our market share with HyaFilia, Cha Meditech's filler brand, at a
rapid pace."